Africa (WHO region) vs Iraq: HIV-positive TB patients on ART (antiretroviral therapy)
Africa (WHO region)
96.0%
in 2024
Iraq
100.0%
in 2021
Africa (WHO region) rank
2nd
Iraq rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Africa (WHO region)
- Iraq
How they compare
Iraq currently reports 100.0% against 96.0% in Africa (WHO region), a difference of 4.0%.
The two have swapped places 2 times across 5 shared years of data; in 2011 it was Iraq ahead.
Africa (WHO region) ranks 2nd and Iraq ranks 1st of 11 groups.
Iraq has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Africa (WHO region) | Iraq | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 66.0% | 66.7% | 0.7% | Iraq |
| 2020s | 91.5% | 100.0% | 8.5% | Iraq |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Africa (WHO region) or Iraq?
- Iraq, at 100.0% against 96.0% in Africa (WHO region) as of 2021.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Africa (WHO region) and Iraq?
- 4.0%, with Iraq ahead.
- How many years of comparable data are there for Africa (WHO region) and Iraq?
- 5 years are reported by both, from 2011 to 2021.
- How do Africa (WHO region) and Iraq rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Africa (WHO region) ranks 2nd and Iraq ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.